The mission of the MSSU-KCU Research Consortium (MKRC) is to engage MSSU and KCU students in inter-disciplinary clinical & basic research opportunities for learning. The MKRC seeks to improve the health of people in the Joplin, Missouri, and Four-States community. The mission of the MKRC is to investigate evidence-based osteopathic medicine through a team-based health care delivery strategy. The presentations by Drs. Arnce and Staudinger will highlight two ongoing clinical research studies at KCU in Joplin.
This presentation focuses only on the randomized, controlled trial data of diabetes medications that explore the impact on cardiovascular outcomes. The majority of this presentation pertains to the following drug classes: DPP-4 inhibitors, SGLT-2, and GLP-1 medications. The main learning goal is to gain an understanding and awareness of the evidenced-based trials that evaluate Type 2 DM medications that meet expectations of cardiovascular risk reduction, and how the American Diabetes Association modified the clinical practice guidelines to reflect these important trial findings.
